Case-Based Roundtable
General Dermatology
Eczema
Chronic Hand Eczema
Chronic Spontaneous Urticaria
Alopecia
Aesthetics
Vitiligo
COVID-19
Actinic Keratosis
Precision Medicine and Biologics
Rare Disease
Wound Care
Rosacea
Psoriasis
Psoriatic Arthritis
Atopic Dermatitis
Melasma
NP and PA
Skin Cancer
Hidradenitis Suppurativa
Drug Watch
Pigmentary Disorders
Acne
Pediatric Dermatology
Practice Management
Prurigo Nodularis
Buy-and-Bill

News

Article

June 24, 2025

Daily Derm Times: June 24, 2025

Author(s):

Emma Andrus, Editor

Key Takeaways

Hershel Dobkin, MD, FAAD, uses humor in dermatology to combat clinical burnout and enhance practice joy.
Teledermatology initiatives in Washington, DC, aim to reduce healthcare disparities and improve access in underserved communities.
Remission in plaque psoriasis is defined as 0% BSA or IGA 0 for at least six months on treatment.
Chronic hand eczema management focuses on personalized care, early treatment, and understanding complex subtypes for better outcomes.

Catch up on dermatology news, highlights, and insights from the past 24 hours.

To stay up-to-date with the latest dermatology news, sign up to receive our eNewsletters.

Laugh Lines and Life Lessons with Hershel Dobkin, MD, FAAD

Discover Hershel Dobkin's unique blend of humor and dermatology, offering insights that combat clinical burnout and bring joy to medical practice.

Derm Dispatch: Creating Equitable Access in Underserved Communities Through Teledermatology

Renata Block, DMSc, MMS, PA-C, speaks with Adam Friedman, MD, FAAD, on innovative teledermatology initiatives in Washington, DC, addressing health care disparities and enhancing community access.

New Consensus Defines Remission in Plaque Psoriasis to Standardize Care

Remission is now defined as 0% BSA or IGA 0 for ≥6 months on treatment, per a Delphi consensus led by the National Psoriasis Foundation.

Optimizing CHE Care: Evolving Strategies for Diagnosis and Management

Explore innovative strategies for managing chronic hand eczema, focusing on personalized care, early treatment, and understanding complex subtypes for better outcomes.

Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.

Subscribe Now!